STOK Stoke Therapeutics posts wider than expected Q4 2025 loss shares gain slightly despite steep earnings miss What should investors watch next for Exelixis EXEL stock Exelixis posts 7 EPS beat vs analyst estimates Moodys Corporation MCO Delivers InvestmentGrade Rating Upgrade to CareTrust REIT Underscoring Healthcare Credit Underwriting Strength NGEN NervGen shares drop 335 percent despite Q3 2025 EPS landing slightly ahead of consensus analyst estimates VHCPU Vine Hill management lays out core 2024 growth priorities after releasing its latest quarterly earnings MasTec MTZ Stock Is It in Consolidation Phase Smart Money Exits 20260427 Is ALT5 Sigma ALTS stock still a good opportunity in 2026 Q2 2025 EPS Misses Estimates Berto Acquisition TACO Stock Is It Worth Opening a Position